Please upgrade your browser.
A kidney cancer patient may be forced to sell his home and move to the North if a last-ditch appeal to his NHS trust for a life-prolonging drug fails.
Nearly two-thirds of kidney cancer patients taking Novartis's RAD001 had progression of their disease delayed by a year, researchers said.
Genentech, Inc. DNA today provided an overview of several clinical studies of Avastin(R) in multiple types of cancer that will be presented during the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place May 30 to June 3 in Chicago.
Renal cell cancer is the lead indication for IL-21, and previously, ZymoGenetics presented interim results from a Phase 1 trial combining IL-21 with Nexavar(R) (sorafenib) tablets.
ANYARA - a novel cancer targeted therapy - is in Phase III trials with 500 advanced renal cell cancer patients.
Nephrectomy before immunotherapy in patients with metastatic renal cell cancer (RCC) will improve patient outcome.
Scientists are studying many diseases and conditions for treatment with Flex-Hets, like polycystic kidney disease, kidney cancer and ovarian cancer.
An interim analysis has been performed in Active Biotech AB's (OMX Nordic: ACTI) ongoing Phase II/III clinical study of ANYARA, in patients with advanced renal cell cancer.
Kidney Cancer Association member and UK activist, Kate Spall, helps cancer patients to get life-extending drugs after her mother lost a battle for treatment.
I never for a moment thought that a life could be decided by something as arbitrary as one's address.
|Powered by NeonCRM|